Glenmark Launches Nutrition Project in Emali, Kenya
26 Jun 2025 //
PR NEWSWIRE
Glenmark Pharmaceuticals launches TEVIMBRA in India
25 Jun 2025 //
INDPHARMAPOST
Glenmark’s Facility Gets 5 FDA Observations Post-Inspection
24 Jun 2025 //
THEHINDU
Glenmark Launches Tevimbra in India for Lung, Esophageal Cancer
24 Jun 2025 //
EXPRESSPHARMA
Glenmark Pharma`s NC facility receives five FDA observations
18 Jun 2025 //
THE HINDU
Enforcement Report - Week of June 18, 2025
18 Jun 2025 //
FDA
Glenmark Pharma to launch DCGI-approved Brukinsa in India
11 Jun 2025 //
INDPHARMAPOST
Enforcement Report - Week of June 4, 2025
04 Jun 2025 //
FDA
Glenmark Pharma reports Q4 FY25 PAT at Rs. 346.6 Cr
24 May 2025 //
INDPHARMAPOST
Enforcement Report - Week of May 7, 2025.pdf
07 May 2025 //
FDA
Delhi HC orders cough syrup makers to warn against child use
24 Apr 2025 //
ECONOMICTIMES
Glenmark to launch generic version of Adderall Tablets
17 Apr 2025 //
EXPRESSPHARM
Enforcement Report - Week of April 16, 2025
16 Apr 2025 //
FDA
Sanofi puts insulin brand Lantus up for sale, eyes Rs 2,000 cr
15 Apr 2025 //
ECONOMICTIMES
Glenmark, Sun Pharma, Zydus recall products in US
13 Apr 2025 //
ECONOMICTIMES
Glenmark, Biocon units recall products in US: USFDA
09 Apr 2025 //
ECONOMICTIMES
Anurag Mantri appointed as President of Glenmark Pharmaceuticals
08 Apr 2025 //
INDPHARMAPOST
Glenmark Pharma launches Vancomycin HCl for injection in US
02 Apr 2025 //
PR NEWSWIRE
Glenmark launches Program to fight malnutrition in Philippines
26 Mar 2025 //
INDPHARMAPOST
Glenmark receives ANDA approval for Olopatadine ophthalmic solution
21 Mar 2025 //
INDPHARMAPOST
Glenmark Pharma launches Empagliflozin and combinations in India
13 Mar 2025 //
INDPHARMAPOST
Glenmark Therapeutics launches Polyethylene Glycol 3350
11 Mar 2025 //
PR NEWSWIRE
Glenmark recalls 1.5M bottles of ADHD drug due to impurities
05 Mar 2025 //
FIERCE PHARMA
Glenmark USA Launches Acetylcysteine Injection 6g/30mL Vial
03 Mar 2025 //
PR NEWSWIRE
FDA Issues Form 483 to Glenmark Pharmaceuticals
03 Mar 2025 //
FDA
Glenmark recalls 1.5 million bottles of ADHD medication in US
02 Mar 2025 //
BUSINESS STD
Glenmark launches Epinephrine injection in US
28 Feb 2025 //
ECONOMICTIMES
Enforcement Report - Week of February 26, 2025
26 Feb 2025 //
FDA
Glenmark Settles U.S. Antitrust Lawsuits for $7M
24 Feb 2025 //
BUSINESS STD
Glenmark, FDC Recall Products From U.S. Over Quality Issues
17 Feb 2025 //
BUSINESS STD
Glenmark Pharma reports Q3 FY25 PAT at Rs. 348 Cr
17 Feb 2025 //
INDPHARMAPOST
India`s Glenmark Pharma Misses Profit Estimates In Q3
14 Feb 2025 //
REUTERS
Glenmark Pharmaceuticals launches Latanoprost Ophthalmic Solution
14 Feb 2025 //
PR NEWSWIRE
Glenmark launches generic ophthalmic solution in US market
13 Feb 2025 //
ECONOMICTIMES
Glenmark launches Clindamycin Phosphate Foam
13 Feb 2025 //
BUSINESS STD
Enforcement Report - Week of February 12, 2025
12 Feb 2025 //
FDA
Glenmark, Cosmo get MHRA nod to acne treatment in UK
10 Feb 2025 //
BUSSINESS STD
Glenmark share rises 2% as unit launches blood clotting drug
21 Jan 2025 //
BUSINESS STD
Glenmark Pharm launch of coagulation disorder drug Phytonadione
21 Jan 2025 //
BUSINESS STD
Enforcement Report - Week of January 1, 2025
01 Jan 2025 //
FDA
Glenmark USA launches Lacosamide Oral Solution, 10 mg/mL
18 Dec 2024 //
INDPHARMAPOST
Glenmark Pharma Shares Up 2% on Rolling Out Lacosamide Solution
16 Dec 2024 //
BUSINESS STD
Glenmark Pharma arm launches seizure drug in US
16 Dec 2024 //
BUSSINESS STD
Aurobindo, Glenmark, Zydus Recall Products in US Over Manufacturing
15 Dec 2024 //
BUSINESS STD
Enforcement Report - Week of December 11, 2024
11 Dec 2024 //
FDA
Glenmark Pharma Gains 4% On Positive Antibody Drug Trials
10 Dec 2024 //
BUSINESS STD
Ichnos Glenmark Presents Data on ISB 2001 in Multiple Myeloma
09 Dec 2024 //
GLOBENEWSWIRE
Glenmark Pharma arm launches Travoprost Ophthalmic Solution in US
27 Nov 2024 //
BUSINESS STD
Glenmark to focus on becoming branded company
19 Nov 2024 //
ECONOMICTIMES
Glenmark arm recalls products in US for manufacturing issues
13 Oct 2024 //
ECONOMICTIMES
Enforcement Report - Week of October 9, 2024
09 Oct 2024 //
FDA
Enforcement Report - Week of October 2, 2024
02 Oct 2024 //
FDA
Ichnos-Glenmark Antibody Outperforms J&J`s Tecvayli In Mice Study
17 Sep 2024 //
FIERCE BIOTECH
Glenmark to pay USD 25 mn as part of settlement with US authorities
05 Sep 2024 //
ECONOMICTIMES
Glenmark Launches OTC Olopatadine Hydrochloride Ophthalmic Solution
19 Aug 2024 //
PR NEWSWIRE
Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP
19 Aug 2024 //
INDIANPHARMAPOST
Glenmark Pharma reports Q1 FY25 consolidated PAT at Rs. 340.2 Cr
15 Aug 2024 //
INDIANPHARMAPOST
Enforcement Report for Week of August 7, 2024
07 Aug 2024 //
FDA
Enforcement Report - Week of July 24, 2024
24 Jul 2024 //
FDA
Glenmark Pharma gets USFDA nod for seizure treatment drug
17 Jul 2024 //
MONEYCONTROL